Hemaptics的动态

Doing now what patients need next

Check Out the latest Canadian Blood Services 2023–2024 Innovation Impact Report! One highlight? The creation of the Canadian Transfusion Trials Group (CTTG)! This national network, led by Dr. Donald Arnold and Dr. Jeannie Callum, is transforming transfusion research through collaboration, data-driven insights, and innovative clinical trials—all aimed at improving patient outcomes. Take a look at the full report for more on this and other groundbreaking initiatives! https://lnkd.in/ghHpSvdb #TransfusionMedicine #ClinicalTrials #Innovation

???????????????? ???? ?????? ??????: The 3rd European #PulmonaryFibrosis Patient Summit opens its doors - in Castelldefels, Spain and virtually on Swapcard. Over three days, patients, experts, researchers, clinicians and others will discuss key aspects of #PF, network, share knowledge and create synergies - and set the agenda for the coming years. Let's drive change together! #PFSUMMIT24

The future of clinical trial site selection is evolving fast. No longer confined by traditional models, we're turning the trial selection process on its head. See our approach - driven by #RWD that's connected to patient counts at more than 7,000 #healthcare sites in the TriNetX network - and learn three key benefits on our blog. https://ow.ly/rgMr50U0At3

M42 appoints Dr. Laila Abdel Wareth?as the Chief Executive Officer of Diagnostics. Leading National Reference Laboratory (NRL), Capital Health Screening Center (CHSC), and?Tawam?Molecular Imaging Centre,?as well as the support to?the imaging?service line?across M42 assets.?Dr. Laila will focus on fostering collaboration and delivering cutting-edge diagnostic solutions to advance patient care. Find out more on the new operating structure?https://bit.ly/4gWZBtv #M42 #Innovation #Healthcare #M42 #GlobalHealth #AIHealthcare #AIHealth

Do not miss your chance to learn from the 4 protocols chosen by peers and panel of experts for their real world innovations in patent hemostasis and preserving radial access Watch now the o webinar on-demand! ??

Cyclopharm is pleased to announce a national agreement with HCA Healthcare, the largest healthcare provider in the U.S., to supply Technegas? across its network of hospitals and imaging centres. This milestone marks a significant step in expanding access to our cutting-edge pulmonary imaging technology, enhancing diagnostic capabilities for patients with respiratory conditions. ? Read the full announcement here: https://lnkd.in/gJCUBsuE ? #Technegas #Cyclopharm #HCAHealthcare #Cyclomedica #CyclomedicaUSA #PulmonaryImaging #NuclearMedicine #HealthcareInnovation #RespiratoryCare #MolecularImaging #PET #SPECT

Excited about attending #NASPAnnual2024 in a few weeks! Looking forward to the Claritas Rx Poster Presentation from 2-3pm EST on Tuesday the 8th. "Harnessing Insights: An In-Depth Look at Benchmarking in Specialty Channels and Patient Services," showcases how benchmarking patient services and channel partner performance can improve patient access to needed treatment. Please stop by Claritas Rx Booth# 500 or the poster session to learn more! #naspconference #benchmarking #growthinsights #specialtypharmacy

Stop by and say hello! While your there, learn how SafeTrace Tx and BloodTrack can help you maximize your blood bank efficiencies.

Anterior cervical disc fusion (ACDF) is the most commonly performed and preferred procedure. Artificial disc replacement (ADR), the same thing? Can motion truly be preserved?